CATX PERSPECTIVE THERAPEUTICS INC revenue, earnings and financials
For the quarter ended June 30, 2026, PERSPECTIVE THERAPEUTICS INC reported revenue of n/a, net income of −$26.8M and diluted EPS of −$0.22; for the fiscal year ended December 2025 revenue was n/a.
CATX annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$114M, net income −$103M (margin n/a), EPS −$1.40
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$90.9M, net income −$79.3M (margin n/a), EPS −$1.23
- Fiscal year ended Dec 2023: revenue $1.43M, gross profit $1.43M, operating income −$40.9M, net income −$46.5M (margin -3243.2%), EPS −$1.74
- Fiscal year ended Dec 2022: revenue $0, gross profit $0, operating income −$8.67M, net income −$10.8M (margin n/a), EPS n/a
- Fiscal year ended Jun 2021: revenue $10.1M, gross profit $5.12M, operating income −$3.45M, net income −$3.39M (margin -33.7%), EPS −$0.03
CATX quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$26.8M, EPS −$0.22
- Quarter ended Mar 31, 2026: revenue n/a, net income −$26.2M, EPS −$0.25
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$37.5M, EPS −$0.51
- Quarter ended Sep 30, 2025: revenue n/a, net income −$26.0M, EPS −$0.35
- Quarter ended Jun 30, 2025: revenue n/a, net income −$21.5M, EPS −$0.29
- Quarter ended Mar 31, 2025: revenue n/a, net income −$18.2M, EPS −$0.25
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$40.2M, EPS −$0.59
- Quarter ended Sep 30, 2024: revenue n/a, net income −$15.1M, EPS −$0.21
- Quarter ended Jun 30, 2024: revenue n/a, net income −$11.7M, EPS −$0.18
- Quarter ended Mar 31, 2024: revenue n/a, net income −$12.3M, EPS −$0.25
- Quarter ended Dec 31, 2023 (from the annual report): revenue −$4.90M (up 31.3% year over year), net income −$24.7M, EPS −$0.97
- Quarter ended Sep 30, 2023: revenue $2.19M (up 27.3% year over year), net income −$10.4M, EPS −$0.37
- Quarter ended Jun 30, 2023: revenue $2.09M (down 16.6% year over year), net income −$11.1M, EPS −$0.40
- Quarter ended Mar 31, 2023: revenue $2.06M (down 29.1% year over year), net income −$371K, EPS $0.00
- Quarter ended Dec 31, 2022 (from the annual report): revenue −$7.13M (down 353.3% year over year), net income −$3.27M, EPS n/a
- Quarter ended Sep 30, 2022: revenue $1.72M (down 33.0% year over year), net income −$4.07M, EPS n/a
- Quarter ended Jun 30, 2022: revenue $2.51M (down 7.6% year over year), net income −$2.08M, EPS n/a
- Quarter ended Mar 31, 2022: revenue $2.91M (up 11.9% year over year), net income −$1.35M, EPS n/a
- Quarter ended Dec 31, 2021: revenue $2.82M, net income −$1.60M, EPS −$0.01
- Quarter ended Sep 30, 2021: revenue $2.56M, net income −$2.24M, EPS −$0.02
CATX cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$82.5M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$18.3M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$36.9M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$10.4M, share buybacks n/a
- Fiscal year ended Jun 2021: operating cash flow −$2.84M, share buybacks n/a
CATX balance sheet
- Jun 30, 2026: cash $48.5M, total assets $392M, total liabilities $68.2M, shareholders' equity $324M
- Mar 31, 2026: cash $54.0M, total assets $411M, total liabilities $63.3M, shareholders' equity $347M
- Dec 31, 2025: cash $30.6M, total assets $267M, total liabilities $59.9M, shareholders' equity $207M
- Sep 30, 2025: cash $26.8M, total assets $295M, total liabilities $52.6M, shareholders' equity $242M
- Jun 30, 2025: cash $28.8M, total assets $311M, total liabilities $45.0M, shareholders' equity $266M
- Mar 31, 2025: cash $44.4M, total assets $329M, total liabilities $44.7M, shareholders' equity $285M
- Dec 31, 2024: cash $61.6M, total assets $341M, total liabilities $50.4M, shareholders' equity $291M
- Sep 30, 2024: cash $226M, total assets $391M, total liabilities $62.7M, shareholders' equity $328M
Is CATX profitable?
No. PERSPECTIVE THERAPEUTICS INC lost $116M over the last four quarters.
What is CATX's EPS?
Diluted earnings per share over the last four quarters were −$1.33; −$0.22 in the latest quarter.